Latest Breaking News On - Completes enrollment - Page 1 : comparemela.com

Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD

Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Frederic guerardArshadm khananiSilvana guerci lenaOpthea limitedVegfd researchExchange commissionOpthea clinical development programLifesci advisorsClinical programInvestment in biotechnology companiesCompletes enrollmentPivotal phaseChief medical advisorAflibercept studyBest corrected visual acuityChief executive officer

MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer

MAIA Biotechnology Completes Enrollment in THIO-101 Phase 2 Clinical Trial for Non-Small Cell Lung Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesBiotechnology incCompletes enrollmentNon small cell lungVlad vitocChief executiveNon small cell lung cancerOverall response rate

Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesChristian marsolaisPhilippe dubucJulie schneidermanSudocetaxel zendusortideIra winerKarmanos cancer centerCommunications corporate affairsTheratechnologies incAmerican society of clinical oncologyDrug administrationCompletes enrollmentFirst six patientsUpdated phaseAdvanced ovarianSenior vice president

Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older

Vaxcyte Completes Enrollment of Phase 1/2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease (IPD) in Adults Aged 50 and Older
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesJanet graesserJennifer zibudaDrug administrationGroupa strepData monitoring committeeVaxcyte incExchange commissionCompany potential pneumococcal conjugate vaccineSutro biopharma incCorporate communicationsCompletes enrollmentInvasive pneumococcal diseaseAdults agedImmunogenicity dataThird quarter

Valneva Reports Half Year 2023 Financial Results and Provides Corporate Updates -September 21, 2023 at 01:01 am EDT

Product sales more than doubled in the first half of 2023 to €69.7 million compared to €33.3 million in the first half of 2022 Driven by IXIARO® and DUKORAL® sales, both of which benefited.

United statesNew zealandUnited kingdomInstituto butantanDeerfield orbimedJoshua drummEuropean union horizonUs department of defense doPan american health organizationGlobal communicationsHealth canadaEuropean unionThird partyCoalition for epidemic preparedness innovationsDrug administrationUs defense logistics agency